NGS in Agrigenomics market size was valued at USD 820 million in 2025.

NGS in Agrigenomics market size was valued at USD 820 million in 2025.

Blog Travel

 

NGS in Agrigenomics Market Insights

Global NGS in Agrigenomics market size was valued at USD 820 million in 2025. The market is forecasted to rise from USD 860 million in 2026 to USD 1.42 billion by 2034, reflecting a CAGR of approximately 6.5% during the forecast period.

Next‑Generation Sequencing applied to agrigenomics encompasses high‑throughput DNA sequencing technologies that enable rapid decoding of plant and animal genomes for breeding, trait discovery, and disease resistance studies. By delivering dense marker data and whole‑genome insights, NGS accelerates genomic selection pipelines and supports precision agriculture initiatives.

📥 Download FREE Sample Report:
NGS in Agrigenomics Market - View in Detailed Research Report

The market is expanding because agricultural biotech firms are allocating larger budgets toward molecular breeding tools, while regulatory frameworks encourage the adoption of data‑driven crop improvement strategies. Moreover, continuous enhancements in sequencing chemistry and cost reductions make large‑scale projects financially viable. For example, in March 2024 Illumina announced a strategic partnership with Bayer to co‑develop a customized sequencing platform aimed at accelerating cereal crop improvement programs. Companies such as Thermo Fisher Scientific, AgriSeq Solutions, and New England Biolabs maintain extensive portfolios that address library preparation, data analysis, and downstream validation needs.

Key Market Drivers

Rising Demand for Precision Breeding
The agricultural sector is embracing genomic‑guided selection to accelerate trait development. Breeders now rely on high‑throughput DNA sequencing to identify disease‑resistant alleles, reducing cycle time from years to months. This shift fuels adoption of next‑generation sequencing platforms across research institutes and private seed companies.

Advancements in Sequencing Technology
Recent enhancements in read length, accuracy, and reagent cost have lowered the economic barrier for routine agrigenomic projects. Instruments that once required multi‑million‑dollar investments now offer pay‑per‑sample models, making large‑scale genotyping feasible for midsized farms. The technology’s scalability directly catalyzes market expansion.

➤ Analysts note that the convergence of cheaper consumables and cloud‑based analytics is reshaping the competitive landscape, prompting legacy vendors to accelerate product roadmaps.

Market Challenges

Data Integration Hurdles
Although raw sequencing output is abundant, transforming reads into actionable breeding decisions requires robust pipelines that can merge genotype, phenotype, and environmental datasets. Many organizations lack the internal expertise to curate such multidimensional information, resulting in delayed implementation of selection strategies.

Regulatory Uncertainty
Policies governing the release of genomically informed cultivars vary widely across regions. Ambiguous guidelines on data privacy and intellectual property can deter investors from committing resources to large‑scale NGS projects.

Market Restraints

High Up‑Front Capital Expenditure
Acquiring state‑of‑the‑art sequencers, establishing clean‑room facilities, and training personnel represent sizable financial commitments. For many agribusinesses operating on thin margins, the initial outlay outweighs short‑term returns, prompting a cautious rollout of sequencing programs.

Market Opportunities

Emerging Applications in Climate‑Resilient Crops
Climate variability is compelling growers to seek varieties that tolerate heat, drought, and salinity. NGS enables rapid identification of alleles linked to stress tolerance, opening a revenue stream for service providers that can deliver custom marker panels. Companies that align their portfolios with these breeding objectives are positioned to capture a growing share of the agrigenomics spend.

Key Statistics:

2025 Market Size

USD 820 million

2034 Projected Market Size

USD 1.42 billion

CAGR (2025–2034)

6.5%

Largest Market in 2025

North America

Key Takeaways: NGS in Agrigenomics Market

  • USD 820 million recorded in 2025 provides a solid platform for expansion.

  • USD 1.42 billion projected for 2034 translates into more than a seventy‑percent uplift over nine years.

  • 6.5% CAGR underscores steady uptake of sequencing across breeding pipelines.

  • North America remains the dominant region, buoyed by deep research networks and strong venture funding.

  • Whole‑genome sequencing commands the largest sub‑segment as breeders prioritize unbiased variant discovery for complex traits.

Analyst Note

The sector benefits from a cascade of cost cuts in reagents and instrument depreciation, turning large‑scale projects into financially sensible choices for midsized seed firms. While capital outlay for cutting‑edge sequencers still deters some adopters, cloud‑based bioinformatics services are lowering the barrier to entry and spawning new revenue streams for service providers. Companies that can stitch together genotype data with emerging phenotyping platforms stand to accelerate breeding cycles dramatically, delivering tangible yield improvements that resonate with both investors and growers.

SEGMENT ANALYSIS

Segment Category

Sub‑Segments

Key Insights

By Type

  • Whole‑genome sequencing

  • Targeted resequencing

Whole‑genome sequencing leads the sub‑segment because it enables comprehensive discovery across diverse crop genomes, supporting unbiased allele identification and downstream marker development.

By Application

  • Marker‑assisted selection

  • Trait discovery

  • Genomic selection

  • Others

Marker‑assisted selection dominates as it translates genomic data into actionable breeding decisions, shortening development timelines and reducing linkage drag.

By End User

  • Seed companies

  • Research institutions

  • Crop growers

Seed companies are the primary users, leveraging NGS to differentiate pipelines, protect intellectual property, and accelerate time‑to‑market.

By Trait Focus

  • Drought tolerance

  • Disease resistance

  • Nutrient‑use efficiency

Disease resistance emerges as the leading focus because it directly supports yield stability and food security.

By Technology Platform

  • Illumina sequencing

  • Pacific Biosciences

  • Oxford Nanopore Technologies

Illumina sequencing dominates due to its reliability, high throughput, and mature analysis ecosystem.

COMPETITIVE LANDSCAPE

NGS‑Enabled Agrigenomics: Competitive Overview

Illumina, Thermo Fisher Scientific, and BGI are the dominant forces shaping the NGS agrigenomics arena. Illumina’s NovaSeq platform, coupled with a robust partner ecosystem for plant‑specific library kits, anchors its market leadership. Thermo Fisher leverages the Scale‑up instrument family and a global service network to capture large breeding programs, while BGI offers cost‑competitive sequencers that appeal to price‑sensitive research institutions in emerging economies.

Beyond the triad, niche players enrich the ecosystem. Oxford Nanopore Technologies provides portable MinION devices enabling field‑based genotyping. Roche’s SeqCap and AgriGenomics’ targeted capture solutions address trait‑focused pipelines. PerkinElmer and Eurofins deliver bio‑informatics services that translate raw reads into actionable markers. Start‑ups such as GeneArt and AgriBioTech specialize in rapid assay development for disease resistance, often co‑developing customized panels with breeding consortia.

List of Key Agrigenomics Companies Profiled

MARKET TRENDS

Rising Cost Competitiveness Accelerates Adoption

Sequencing reagents and instrument depreciation costs have fallen by roughly 40 % over the past year, bringing per‑sample expenses within reach of midsized seed firms and university programs. The shift is prompting many laboratories to repatriate workflows in‑house, shrinking turnaround times from weeks to days and fostering direct hiring of bioinformatic talent.

Synergy with Digital Phenotyping Platforms

High‑resolution imaging and sensor networks now enable genotype‑to‑phenotype matching at field scale. Early adopters report breeding‑cycle reductions of up to 20 % by eliminating redundant field trials and focusing resources on genetically promising lines.

Regulatory Alignment Enhances Data Sharing

Harmonized data‑privacy guidelines across major agricultural jurisdictions have lowered legal friction for cross‑border collaborations. Standardized repositories accelerate joint breeding initiatives and expand the genetic diversity pool available for elite cultivar development.

REGIONAL ANALYSIS

North America
North America leads the market, powered by a mature research ecosystem, significant private‑sector investment, and a regulatory climate that encourages genomic innovation. Federal grants and venture capital fuel startups that integrate sequencing with advanced phenotyping, while large agro‑chemical corporations expand in‑house NGS capabilities to protect proprietary pipelines.

Europe
European nations leverage strong public research networks and sustainability‑driven policies to promote NGS‑enabled precision breeding, particularly for low‑phosphorus and environmentally friendly traits.

Asia‑Pacific
The region’s extensive arable land and climate challenges drive governmental incentive schemes, fostering partnerships between local seed firms and multinational NGS service providers. Disparities in data infrastructure create pockets of uneven progress, attracting investors to emerging bio‑informatics hubs.

South America
Commodity‑focused agribusinesses in Brazil and Argentina adopt NGS to boost drought resilience and disease resistance, with financing often sourced from export‑driven capital markets.

Middle East & Africa
Harsh environments stimulate interest in heat‑ and salt‑tolerant cultivars. Donor‑funded pilot projects are seeding early‑stage collaborations between regional universities and global sequencing platforms.

REPORT SCOPE

This market research report offers a holistic overview of global and regional markets for the forecast period 2026–2034. It presents accurate and actionable insights based on a blend of primary and secondary research.